Abola P, Jabishvili G. Incidence of Adverse and Safety Events in Individuals with Parkinson’s Disease Treated with Catechol-O-Methyltransferase Inhibitor Opicapone as an Add-On to Levodopa Treatment: A Systematic Review and Meta-Analysis. Prospect. Pharm. Sci. [Internet]. 2025 Aug. 13 [cited 2025 Oct. 2];(2025 (Early Access). Available from: https://prospects.wum.edu.pl/index.php/pps/article/view/563